Two Sigma Advisers
IRMD icon

Two Sigma Advisers’s iRadimed IRMD Stock Holding History

Two Sigma Advisers’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,400
Closed -$4.12M – 1063
2025
Q4 		$4.12M Buy
42,400
+7,100
+20% +$609K 0.01% 902
2025
Q3 		$2.51M Sell
35,300
-6,400
-15% -$426K 0.01% 1031
2025
Q2 		$2.49M Buy
41,700
+5,800
+16% +$318K 0.01% 1013
2025
Q1 		$1.88M Sell
35,900
-1,100
-3% -$61.8K ﹤0.01% 1178
2024
Q4 		$2.04M Sell
37,000
-13,100
-26% -$689K ﹤0.01% 1116
2024
Q3 		$2.52M Sell
50,100
-800
-2% -$36.9K 0.01% 964
2024
Q2 		$2.24M Buy
50,900
+19,400
+62% +$825K 0.01% 1127
2024
Q1 		$1.39M Buy
31,500
+1,800
+6% +$79.6K ﹤0.01% 1410
2023
Q4 		$1.41M Sell
29,700
-4,200
-12% -$177K ﹤0.01% 1466
2023
Q3 		$1.5M Buy
33,900
+8,800
+35% +$409K ﹤0.01% 1340
2023
Q2 		$1.2M Buy
25,100
+8,900
+55% +$401K ﹤0.01% 1466
2023
Q1 		$637K Sell
16,200
-1,200
-7% -$43.6K ﹤0.01% 1842
2022
Q4 		$492K Sell
17,400
-700
-4% -$20K ﹤0.01% 1882
2022
Q3 		$544K Sell
18,100
-10,300
-36% -$359K ﹤0.01% 1810
2022
Q2 		$964K Sell
28,400
-7,400
-21% -$265K ﹤0.01% 1614
2022
Q1 		$1.6M Buy
35,800
+4,000
+13% +$185K ﹤0.01% 1380
2021
Q4 		$1.47M Buy
31,800
+15,000
+89% +$605K ﹤0.01% 1350
2021
Q3 		$564K Buy
+16,800
New +$571K ﹤0.01% 1877
2019
Q3 		– Sell
-12,300
Closed -$252K – 2305
2019
Q2 		$252K Sell
12,300
-2,300
-16% -$54.2K ﹤0.01% 2071
2019
Q1 		$410K Buy
14,600
+2,000
+16% +$52.3K ﹤0.01% 1866
2018
Q4 		$308K Sell
12,600
-200
-2% -$5.37K ﹤0.01% 1971
2018
Q3 		$476K Buy
+12,800
New +$345K ﹤0.01% 1813

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's IRMD Position: Q1 2026 in Review

Two Sigma Advisers sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 42,400 shares — an estimated $4.12M sold.

Two Sigma Advisers first reported a position in IRMD in Q3 2018 and held it in 22 quarters. The position peaked at $4.12M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Two Sigma Advisers reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 42,400 iRadimed shares in Q1 2026, an estimated $4.12M.
  • Two Sigma Advisers first reported a position in iRadimed in Q3 2018 and held it in 22 quarters.
  • Two Sigma Advisers's iRadimed position peaked at $4.12M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.